Eve Pharma

The only diagnostic + treatment drug for Bacterial Vaginosis Eve Pharma’s vaginal tablet has a special coating which dissolve only in specific pH levels (4.5 – 4.7), which are concusses of the Vaginal Bacteria. Once the coating is dissolve, Metronidazole is released and treats Bacterial Vaginosis EVE Pharma coated tablets is “once and done” diagnostic and therapeutic tool. Bacterial vaginosis (BV)- the most common vaginal infection in women. BV without treatment: Increases the risk of preterm birth, with low birth weight in new-borns most expensive hospitalization patients’ expense for the health care system. Significantly increases the risk of contracting sexually transmitted diseases, especially HIV. OTC- there are over-the-counter medications designed for fungal infections, patients first turn to using this drug, which prolongs the duration of the infection and delays the solution for BV. Poor diagnosis, leads to excessive and unnecessary use of antibiotics, exacerbates the symptoms and increases the risk to the patient. One in three women will suffer from Bacterial Vaginosis in her lifetime. Based on the four Amsel criteria that include the tests: Higher than normal pH in vagina <4.5-4.7 Typical vaginal discharge. Presence of over 20% clue cells KOH test for Gray and fishy smell like odor In practice, doctors rarely preform all (or any) test Hence Bacterial Vaginosis is often undiagnosed or misdiagnosed as a fungal infection. The company's management consists of a serial entrepreneur and a team with experience in launching, marketing, sales and regulation in the fields of pharmaceuticals and medical equipment, and were involved in recruited capital, M&A, IPOs and sold companies in the past.